- Conditions
- End-Stage Renal Disease, Hemodialysis Catheter-associated Infection
- Interventions
- catheter lock solution consisting of N-acetylcystein, tigecycline and heparin
- Drug
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 3
- States / cities
- Houston, Texas
Source: ClinicalTrials.gov public record
Updated Oct 8, 2019 · Synced May 21, 2026, 11:10 PM EDT